Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 15,902 | 23,720 | 6,079 | 3,947 | 5,090 |
| Cost of Goods | 2,879 | 1,444 | 1,249 | 763 | 951 |
| Gross Profit | 13,023 | 22,275 | 4,830 | 3,184 | 4,139 |
| Operating Expenses | 58,294 | 49,791 | 46,716 | 42,052 | 43,210 |
| Operating Income | -44,392 | -27,071 | -41,637 | -38,105 | -38,121 |
| Interest Expense | 5,664 | 5,599 | 4,029 | 2,090 | 2,093 |
| Other Income | 621 | 704 | -9,571 | 689 | 823 |
| Pre-tax Income | -49,436 | -31,967 | -55,237 | -39,506 | -39,391 |
| Net Income Continuous | -49,436 | -31,967 | -55,237 | -39,506 | -39,391 |
| Net Income | $-49,436 | $-31,967 | $-55,237 | $-39,506 | $-39,391 |
| EPS Basic Total Ops | -10.00 | -6.50 | -11.50 | -8.00 | -8.50 |
| EPS Basic Continuous Ops | -9.48 | -6.62 | -11.45 | -8.20 | -8.36 |
| EPS Diluted Total Ops | -10.00 | -6.50 | -11.50 | -8.00 | -8.50 |
| EPS Diluted Continuous Ops | -9.48 | -6.62 | -11.45 | -8.20 | -8.36 |
| EBITDA(a) | $-43,963 | $-26,647 | $-41,325 | $-37,878 | $-37,905 |